{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:31:24Z","timestamp":1791228684838,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.neulet.2013.09.014","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T07:31:40Z","timestamp":1379057500000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Altered expression of miR-146a in myasthenia gravis"],"prefix":"10.1016","volume":"555","author":[{"given":"Jiayin","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-fa","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neulet.2013.09.014_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cacc.2007.01.006","article-title":"A review of myasthenia gravis: pathogenesis, clinical features and treatment","volume":"18","author":"Chris","year":"2007","journal-title":"Curr. Anaesth. Crit. Care"},{"issue":"9274","key":"10.1016\/j.neulet.2013.09.014_bib0010","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.neulet.2013.09.014_bib0015","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.34.4.462","article-title":"Thymic B-cell activation in myasthenia gravis","volume":"34","author":"Levinson","year":"1984","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neulet.2013.09.014_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/08916939908993860","article-title":"Cell-surface expression of lymphocyte activation markers in myasthenia gravis","volume":"31","author":"Ragheb","year":"1999","journal-title":"Autoimmunity"},{"issue":"11","key":"10.1016\/j.neulet.2013.09.014_bib0025","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1101\/gad.1919710","article-title":"Emerging paradigms of regulated microRNA processing","volume":"24","author":"Newman","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.neulet.2013.09.014_bib0030","doi-asserted-by":"crossref","first-page":"437301","DOI":"10.4061\/2011\/437301","article-title":"MiR-146a in immunity and disease","volume":"2011","author":"Rusca","year":"2011","journal-title":"Mol. Biol. Int."},{"issue":"1","key":"10.1016\/j.neulet.2013.09.014_bib0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000301938","article-title":"MicroRNA-146: tiny player in neonatal innate immunity?","volume":"99","author":"Lederhuber","year":"2011","journal-title":"Neonatology"},{"key":"10.1016\/j.neulet.2013.09.014_bib0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-8722-5-13","article-title":"The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer","volume":"5","author":"Labbaye","year":"2012","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.neulet.2013.09.014_bib0045","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/gb-2005-6-8-r71","article-title":"MicroRNA profiling of the murine hematopoietic system","volume":"6","author":"Monticelli","year":"2005","journal-title":"Genome Biol."},{"issue":"33","key":"10.1016\/j.neulet.2013.09.014_bib0050","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.neulet.2013.09.014_bib0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2009-06-225987","article-title":"An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes","volume":"115","author":"Curtale","year":"2010","journal-title":"Blood"},{"issue":"42","key":"10.1016\/j.neulet.2013.09.014_bib0060","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1038\/onc.2008.171","article-title":"Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells","volume":"27","author":"Bhaumik","year":"2008","journal-title":"Oncogene"},{"issue":"52","key":"10.1016\/j.neulet.2013.09.014_bib0065","doi-asserted-by":"crossref","first-page":"19075","DOI":"10.1073\/pnas.0509603102","article-title":"The role of microRNA genes in papillary thyroid carcinoma","volume":"102","author":"He","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.neulet.2013.09.014_bib0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1261\/rna.874808","article-title":"Loss of mir-146a function in hormone-refractory prostate cancer","volume":"14","author":"Lin","year":"2008","journal-title":"RNA"},{"issue":"4","key":"10.1016\/j.neulet.2013.09.014_bib0075","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-09-2792","article-title":"miR-146a suppresses invasion of pancreatic cancer cells","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.neulet.2013.09.014_bib0080","doi-asserted-by":"crossref","first-page":"e2557","DOI":"10.1371\/journal.pone.0002557","article-title":"Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth","volume":"3","author":"Wang","year":"2008","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.neulet.2013.09.014_bib0085","doi-asserted-by":"crossref","first-page":"e30832","DOI":"10.1371\/journal.pone.0030832","article-title":"MicroRNA 146a (miR-146a) is over-expressed during Prion disease and modulates the innate immune response and the microglial activation state","volume":"7","author":"Saba","year":"2012","journal-title":"PLoS ONE"},{"issue":"50","key":"10.1016\/j.neulet.2013.09.014_bib0090","doi-asserted-by":"crossref","first-page":"38951","DOI":"10.1074\/jbc.M110.178848","article-title":"Differential regulation of interleukin-1 receptor-associated kinase-1(IRAK-1) and IRAK-2 by microRNA-146a and NF-kappa B in stressed human astroglial cells and in Alzheimer disease","volume":"285","author":"Cui","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neulet.2013.09.014_bib0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12035-012-8234-4","article-title":"Regulation of complement factor H(CFH) by multiple miRNAs in Alzheimer's disease (AD) brain","volume":"46","author":"Lukiw","year":"2012","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.neulet.2013.09.014_bib0100","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1460-9568.2010.07122.x","article-title":"Expression pattern of miR-146a, an inflammation\u2013associated microRNA, in experimental and human temporal lobe epilepsy","volume":"31","author":"Aronica","year":"2010","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.neulet.2013.09.014_bib0105","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.24436","article-title":"MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins","volume":"60","author":"Tang","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.neulet.2013.09.014_bib0110","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar2493","article-title":"Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"10","author":"Pauley","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.neulet.2013.09.014_bib0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1471-2474-11-209","article-title":"MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients","volume":"11","author":"Niimoto","year":"2010","journal-title":"BMC Musculoskelet. Disord."},{"issue":"1","key":"10.1016\/j.neulet.2013.09.014_bib0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neulet.2011.08.021","article-title":"Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis","volume":"504","author":"Fenoglio","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.neulet.2013.09.014_bib0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.imlet.2011.09.006","article-title":"Increased microRNA-146a\/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sj\u00f6gren's syndrome","volume":"141","author":"Zilahi","year":"2012","journal-title":"Immunol. Lett."},{"issue":"7","key":"10.1016\/j.neulet.2013.09.014_bib0130","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/eji.201040757","article-title":"Altered miR-146a expression in Sj\u00f6gren's syndrome and its functional role in innate immunity","volume":"41","author":"Pauley","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neulet.2013.09.014_bib0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1034\/j.1600-065x.2001.1840111.x","article-title":"Rat models as tool to develop new immunotherapies","volume":"184","author":"Link","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.neulet.2013.09.014_bib0140","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1196\/annals.1254.033","article-title":"Immunoregulation in experimental autoimmune myasthenia gravis\u2014about T cells, antibodies, and endplates","volume":"998","author":"De Baets","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.neulet.2013.09.014_bib0145","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1172\/JCI8121","article-title":"Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment","volume":"104","author":"Im","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.neulet.2013.09.014_bib0150","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.4049\/jimmunol.146.7.2245","article-title":"Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis","volume":"146","author":"Lennon","year":"1991","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.neulet.2013.09.014_bib0155","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1002\/eji.200636483","article-title":"TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells","volume":"37","author":"Barr","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.neulet.2013.09.014_bib0160","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.0903253","article-title":"TLR4 promotes B cell maturation: independence and cooperation with B lymphocyte-activating factor","volume":"184","author":"Hayashi","year":"2010","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.neulet.2013.09.014_bib0165","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.icb.7100097","article-title":"Regulating B-cell activation and survival in response to TLR signals","volume":"85","author":"Gerondakis","year":"2007","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.neulet.2013.09.014_bib0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10753-012-9526-6","article-title":"Possible involvement of Toll-like receptors in the pathogenesis of myasthenia gravis","volume":"67","author":"Wang","year":"2013","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.neulet.2013.09.014_bib0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0002-9440(10)62960-4","article-title":"Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution","volume":"167","author":"Bernasconi","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.neulet.2013.09.014_bib0180","first-page":"311","article-title":"Expression of Toll-like receptors in thymus of myasthenia gravis patients","volume":"25","author":"Gao","year":"2008","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394013008306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394013008306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T11:15:46Z","timestamp":1688469346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394013008306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":36,"alternative-id":["S0304394013008306"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2013.09.014","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered expression of miR-146a in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2013.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}